CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation

Cancer Cell. 2010 Nov 16;18(5):485-98. doi: 10.1016/j.ccr.2010.10.002. Epub 2010 Oct 28.

Abstract

Oncogene addiction is thought to occur cell autonomously. Immune effectors are implicated in the initiation and restraint of tumorigenesis, but their role in oncogene inactivation-mediated tumor regression is unclear. Here, we show that an intact immune system, specifically CD4(+) T cells, is required for the induction of cellular senescence, shutdown of angiogenesis, and chemokine expression resulting in sustained tumor regression upon inactivation of the MYC or BCR-ABL oncogenes in mouse models of T cell acute lymphoblastic lymphoma and pro-B cell leukemia, respectively. Moreover, immune effectors knocked out for thrombospondins failed to induce sustained tumor regression. Hence, CD4(+) T cells are required for the remodeling of the tumor microenvironment through the expression of chemokines, such as thrombospondins, in order to elicit oncogene addiction.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Apoptosis / physiology
  • CD4-Positive T-Lymphocytes / immunology*
  • Cell Proliferation / drug effects
  • Cellular Senescence / drug effects
  • Chemokines / genetics
  • Chemokines / metabolism
  • Cyclosporine / pharmacology
  • Fusion Proteins, bcr-abl / genetics
  • Gene Expression Regulation, Neoplastic
  • Gene Silencing
  • Immunosuppressive Agents / pharmacology
  • Leukemia, Experimental / genetics
  • Leukemia, Experimental / immunology
  • Mice
  • Mice, Transgenic
  • Neoplasms / genetics
  • Neoplasms / immunology
  • Neoplasms / pathology
  • Neovascularization, Pathologic / genetics
  • Neovascularization, Pathologic / immunology
  • Oncogenes / genetics*
  • Proto-Oncogene Proteins c-myc / genetics
  • Remission Induction
  • Thrombospondin 1 / genetics
  • Thrombospondin 1 / metabolism
  • Tumor Microenvironment / drug effects
  • Tumor Microenvironment / genetics
  • Tumor Microenvironment / immunology*

Substances

  • Chemokines
  • Immunosuppressive Agents
  • Proto-Oncogene Proteins c-myc
  • Thrombospondin 1
  • Cyclosporine
  • Fusion Proteins, bcr-abl